The transfer portal strikes again, this time claiming one of the Virginia Cavaliers' younger stars, Kameron Courtney. Since the portal opened today, UVA players have been hustling and making moves, ...

Icecure Medical ( (ICCM)) just unveiled an update. On December 10, 2025, IceCure Medical announced that its ProSense® Cryoablation technology was featured in four independent studies presented at the ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer tumors to kill them — is emerging as a new option. The FDA recently granted ...

IceCure Medical Ltd. (NASDAQ:ICCM), the developer of minimally invasive cryoablation technology that destroys tumors by freezing them, was granted marketing authorization from the U.S. Food and Drug ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icecure Medical ( (ICCM)) has shared an ...

PHOENIX (AZFamily) — There’s a new kind of breast cancer treatment that involves no chemotherapy, no radiation, and no surgery. It may seem to good to be true, but this Breast Cancer Awareness month, ...

The ProSense® Cryoablation System could be a game changer for women over 70 with early-stage, low-risk breast cancer. For decades, breast cancer treatment has often meant surgery, which can be an ...

Icecure Medical Ltd. reported that the U.S. FDA has granted marketing authorization to Icecure's de novo application for the Prosense cryoablation system for the local treatment of breast cancer in ...

"ProSense® offers the first new innovation in the treatment of women aged 70 and above with low-risk early-stage breast cancer in decades. We are proud to deliver a significant advancement and ...

SANDY — More people are experiencing chronic digestive health conditions and colon cancer is being diagnosed at younger ages, prompting one of Utah's largest health care companies to increase options ...

When cancer returned last year, it did so in a very different chapter of her life. This time, a rare stage IV sarcoma complicated her breast cancer. She now faced a difficult decision regarding ...